These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30773626)

  • 1. From Molecule to Patient and Ways to Get the Dose Precisely Right.
    Vinks AA
    Clin Pharmacol Ther; 2019 Mar; 105(3):534-537. PubMed ID: 30773626
    [No Abstract]   [Full Text] [Related]  

  • 2. Discussion: The FDA is Unprepared for Personalized Medicine.
    Tabarrok A
    Biostatistics; 2017 Jul; 18(3):403-404. PubMed ID: 28633317
    [No Abstract]   [Full Text] [Related]  

  • 3. Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Alcohol Clin Exp Res; 2020 Jan; 44(1):23-35. PubMed ID: 31803968
    [No Abstract]   [Full Text] [Related]  

  • 4. Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps.
    Printz C
    Cancer; 2020 Jan; 126(2):239-240. PubMed ID: 31917472
    [No Abstract]   [Full Text] [Related]  

  • 5. A precision medicine approach to pharmacological adjuncts to extinction: a call to broaden research.
    King G; Baker KD; Bisby MA; Chan D; Cowan CSM; Stylianakis AA; Zimmermann KS; Richardson R
    Psychopharmacology (Berl); 2019 Jan; 236(1):143-161. PubMed ID: 30116858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Changing Face of Oncology Research, Drug Development, and Clinical Practice: Toward Patient-Focused Precision Therapeutics.
    Venkatakrishnan K; van der Graaf PH; Holstein SA
    Clin Pharmacol Ther; 2020 Sep; 108(3):399-404. PubMed ID: 33439492
    [No Abstract]   [Full Text] [Related]  

  • 7. Precision Medicine Is Not Just Genomics: The Right Dose for Every Patient.
    Peck RW
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():105-122. PubMed ID: 28961067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Dosing: An Industry Perspective.
    Peck RW
    Clin Pharmacol Ther; 2021 Jan; 109(1):47-50. PubMed ID: 33107023
    [No Abstract]   [Full Text] [Related]  

  • 9. Can precision medicine reduce overdiagnosis?
    Hunt S; Jha S
    Acad Radiol; 2015 Aug; 22(8):1040-1. PubMed ID: 26100198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends.
    Liu Q; Ahadpour M; Rocca M; Huang SM
    AAPS J; 2021 Apr; 23(3):54. PubMed ID: 33846878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic Natural Products as an Approach Towards the Development of Therapeutic Agents for Precision Medicine.
    Rijo P
    Curr Pharm Des; 2018; 24(36):4205-4206. PubMed ID: 30821216
    [No Abstract]   [Full Text] [Related]  

  • 12. Physiologically-Based Pharmacokinetic Models as Enablers of Precision Dosing in Drug Development: Pivotal Role of the Human Mass Balance Study.
    Rowland Yeo K; Venkatakrishnan K
    Clin Pharmacol Ther; 2021 Jan; 109(1):51-54. PubMed ID: 33220063
    [No Abstract]   [Full Text] [Related]  

  • 13. Learning for Personalized Medicine: A Comprehensive Review From a Deep Learning Perspective.
    Zhang S; Bamakan SMH; Qu Q; Li S
    IEEE Rev Biomed Eng; 2019; 12():194-208. PubMed ID: 30106692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing cancer drug development through precision medicine and innovative designs.
    Zhang W; Wang J; Menon S
    J Biopharm Stat; 2018; 28(2):229-244. PubMed ID: 29173004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
    Lauschke VM; Ingelman-Sundberg M
    Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unveiling the Genetic Architecture of Human Disease for Precision Medicine.
    Ramamoorthy A; Yee SW; Karnes J
    Clin Transl Sci; 2019 Jan; 12(1):3-5. PubMed ID: 30474919
    [No Abstract]   [Full Text] [Related]  

  • 17. Accelerating anticancer drug development - opportunities and trade-offs.
    Nass SJ; Rothenberg ML; Pentz R; Hricak H; Abernethy A; Anderson K; Gee AW; Harvey RD; Piantadosi S; Bertagnolli MM; Schrag D; Schilsky RL
    Nat Rev Clin Oncol; 2018 Dec; 15(12):777-786. PubMed ID: 30275514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precision Medicine 2030.
    Pacanowski M; Liu Q
    Clin Pharmacol Ther; 2020 Jan; 107(1):62-64. PubMed ID: 31782136
    [No Abstract]   [Full Text] [Related]  

  • 19. Precision dosing in clinical medicine: present and future.
    Polasek TM; Shakib S; Rostami-Hodjegan A
    Expert Rev Clin Pharmacol; 2018 Aug; 11(8):743-746. PubMed ID: 30010447
    [No Abstract]   [Full Text] [Related]  

  • 20. Implementing Clinical Prediction Models: Pushing the Needle Towards Precision Pharmacotherapy.
    Dorajoo SR; Chan A
    Clin Pharmacol Ther; 2018 Feb; 103(2):180-183. PubMed ID: 28722146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.